Top Markets
Coin of the day
Augmedix, Inc. Augmedix, Inc.

Augmedix, Inc.

AUGX
Pozycja w akcjach #22478
Augmedix, Inc. is a U.S.-based company specializing in remote medical... Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Cena akcji
$2.35
Ostatnia synchronizacja: 2024-10-02
Kapitalizacja rynkowa
$87.95M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Augmedix, Inc. (AUGX)

Kategoria

Zyski dla Augmedix, Inc. (AUGX)
Zyski w Jun 2024 TTM: $-23.87M
Według najnowszych raportów finansowych Augmedix, Inc., obecny zysk firmy wynosi $-23.87M. W roku 2022 firma osiągnęła zysk w wysokości $-24.45M, spadek w porównaniu do zysku z roku 2021, który wynosił $-17.85M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Augmedix, Inc. od 2018 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-23.87M 25.43%
2023 $-19.03M -22.18%
2022 $-24.45M 36.96%
2021 $-17.85M 14.40%
2020 $-15.60M -15.65%
2019 $-18.50M -23.44%
2018 $-24.16M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$2.04B -8,660.65%
US
$266.26M -1,215.68%
AU
$-259.89M 989.02%
US
$295.53M -1,338.35%
US
- -
US